Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
To date, no appellate court has ruled that physicians must disclose off-label status as part of informed consent
This matters as a new cornerstone therapy in type 2 diabetes (T2DM), glucagon-like peptide-1 receptor agonists (GLP-1), are entering broader use, necessitating a deeper dive into how this treatment interacts, directly or indirectly, with pathways influenced by sex hormones
41 imposes sweeping new requirements on PBMs operating in the state, and PCMA is arguing that S.B
doi: 10.1210/jc.2004-1719 98 MericqVCassorlaFBowersCYAvilaAGonenBMerriamGR
US$ 23.00
US$ 26.60
US$ 20.07
US$ 20.06
US$ 28.79
